SEC Filings TLDR

On August 1, 2025, Sharyn Leaver, Chief Research Officer of Forrester Research, Inc., converted 826 restricted stock units (RSUs) into common stock. These RSUs were part of a grant awarded on August 2, 2021, which vested in four equal installments on August 1, 2022, 2023, 2024, and 2025. Additionally, 237 shares were w...

On August 1, 2025, Carrie Johnson, Chief Product Officer of Forrester Research, Inc., vested 2,203 Restricted Stock Units (RSUs) which converted into common stock. Additionally, 822 shares were withheld by the company to satisfy tax withholding obligations related to the vesting of these RSUs. The RSUs were originally ...

On August 1, 2025, Krishna Vanka, CEO and President of Flux Power Holdings, Inc., was granted 121,951 time-based restricted stock units (RSUs) and 182,927 performance-based RSUs under the company's 2021 Equity Incentive Plan. The time-based RSUs are scheduled to vest annually over three years, starting on July 1, 2026,...

On August 1, 2025, Kevin Royal, the CFO and Secretary of Flux Power Holdings, Inc., was granted 84,150 incentive stock options at an exercise price of $1.88. The options were granted under the company's 2021 Equity Incentive Plan and will vest annually over three years from the grant date. The exercise price is based o...

On August 1, 2025, Flux Power Holdings, Inc. (FLUX) granted 56,100 incentive stock options to Jeffrey Curtis Mason, the company's Chief Operating Officer. The options were granted under the company's 2021 Equity Incentive Plan and have an exercise price of $1.88, which is based on the 10-day volume weighted average pri...

Ming Hsieh, Chief Executive Officer and a ten percent owner of Fulgent Genetics, Inc., filed a Form 4 with the SEC on August 5, 2025, reporting transactions on August 1, 2025. The filing details the withholding of 1,339 shares to satisfy tax obligations arising from the vesting of restricted stock units granted on Augu...

On August 1, 2025, Andy Dignan, President of Five9, Inc., sold 700 shares of the company's common stock at a price of $26.16 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted on December 10, 2024. Following the sale, Dignan owns 225,739 shares of Five9, Inc. The filing, submitted on Augu...

The SEC filing reports transactions involving Graham Poliner, an officer of Five Below, Inc. (ticker: FIVE). On June 30, 2025, Poliner acquired 43 shares of common stock at a price of $118.06 per share under a Stock Purchase Plan exempt under Rule 16b-3(c). Following this transaction, Poliner owned 20,657 shares. On Au...

On August 1, 2025, Eric M. Specter, the Chief Accounting Officer (CAO) of Five Below, Inc., sold 1,987 shares of the company's common stock at a price of $133.16 per share. Following this transaction, Specter's total ownership in Five Below, Inc. decreased to 53,867 shares. The transaction was reported under Form 4, in...

On August 1, 2025, Ronald J. Masciantonio, EVP and General Counsel of Five Below, Inc., sold 663 shares of the company's common stock at a price of $133.16 per share. Following this transaction, Masciantonio owns 11,337 shares of Five Below, Inc. common stock. The sale was reported in a Form 4 filing with the SEC, indi...

On August 1, 2025, Amit Jhunjhunwala, the Chief Information Officer of Five Below, Inc., sold 1,439 shares of the company's common stock at a price of $133.16 per share. Following this transaction, Jhunjhunwala owns 24,451 shares of Five Below, Inc. The transaction was reported in a Form 4 filing with the SEC. This sal...

On August 1, 2025, Maureen Gellerman, the Chief Human Resources Officer (CHRO) of Five Below, Inc., sold 613 shares of the company's common stock at a price of $133.16 per share. Following this transaction, Gellerman owns 12,738 shares of Five Below, Inc. common stock. The sale was reported in a Form 4 filing with the ...

On August 1, 2025, George Hill, the Chief Retail Officer of Five Below, Inc., disposed of 1,355 shares of common stock at a price of $133.16 per share. Following this transaction, Hill owns a total of 41,317 shares of common stock. The transaction was reported in a Form 4 filing with the SEC. Hill's ownership is direct...

On August 1, 2025, Kenneth R. Bull, the Chief Operating Officer (COO) and Interim Chief Financial Officer (CFO) of Five Below, Inc., disposed of 2,655 shares of the company's common stock at a price of $133.16 per share. Following this transaction, Bull still owns 123,068 shares of the company's common stock. The trans...

On August 1, 2025, Larry G. Swets, Jr., Head of Merchant Banking at Fundamental Global Inc., acquired 79 shares of the company's common stock at a price of $26.915 per share. These shares were purchased under the Employee Share Purchase Plan. Following this transaction, Swets owns a total of 24,347 shares of Fundamenta...

On August 5, 2025, Rosty Raykov, a director of Fennec Pharmaceuticals Inc., sold 10,000 common shares at a price of $8.09 per share. This transaction was conducted pursuant to a 10b5-1 plan dated August 23, 2024. Following the sale, Raykov owns 55,878 common shares. The sale was reported in a Form 4 filing with the SEC...

The SEC filing details the transactions of Eugene J Walsh, VP & COO of Fidelity D & D Bancorp Inc (FDBC), involving restricted stock grants and stock appreciation rights. On July 25, 2025, Walsh disposed of 3,759.0607 shares of restricted common stock, leaving him with 9,811.3714 shares. The filing also notes that all ...

Ralph Mattox Snow III, a director of First Citizens BancShares Inc., filed a Form 4 with the SEC on August 5, 2025. The filing reports the acquisition of 10 Class A Common shares at a price of $1,888.5978 per share. Following this transaction, Snow owns a total of 110 Class A Common shares. The filing also includes a L...

On August 4, 2025, Craig L. Nix, the Chief Financial Officer of First Citizens Bancshares Inc, reported transactions involving the company's securities. Nix acquired 6 shares of Class A Common stock at a price of $1,958.74 per share, increasing his total holdings of this stock to 1,147 shares. Additionally, he holds 9,...

James H. Graves, a director of FirstCash Holdings, Inc., reported two transactions involving the company's common stock on August 4, 2025. First, he sold 6,000 shares at a price of $134.56 per share, reducing his holdings to 15,846 shares. Second, he gifted 1,000 shares to a charitable organization, further reducing hi...

Cindy Tahl, the Chief Legal and Compliance Officer of Fate Therapeutics Inc, sold 9,037 shares of common stock on August 4, 2025, at a weighted average price of $1.0593 per share. This sale was executed to cover tax withholding obligations related to the vesting of 25,000 shares of Common Stock underlying RSUs granted ...

On August 4, 2025, Bahram Valamehr, President and CEO of Fate Therapeutics Inc., sold 14,466 shares of common stock at a weighted average price of $1.0643 per share. This sale was executed to cover tax withholding obligations related to the vesting of 25,000 shares of Common Stock underlying RSUs granted on July 29, 20...

On August 1, 2025, Nadal Toni Thompson, the Chief Human Resources Officer of ETSY INC, engaged in several stock transactions. Thompson acquired 4,650 shares of common stock upon the vesting of restricted stock units, increasing their total holdings to 7,424 shares. Additionally, 1,841 shares were withheld by the compan...

Merilee Buckley, the Chief Accounting Officer of ETSY INC, sold 5,817 shares of common stock on August 4, 2025. The shares were sold at a weighted average price of $58.83 per share, with the actual sale prices ranging from $58.46 to $59.09 per share. Following this transaction, Buckley no longer holds any shares of ETS...

Josh Silverman, the Chief Executive Officer and Director of ETSY INC, reported several stock transactions on August 1, 2025. These transactions included the exercise of employee stock options and the sale of common stock. The stock options were part of a grant that vested as to 25% on May 4, 2018, with the remainder ve...